Image Image Image Image Image Image Image Image Image Image
Доступ
Идти наверх

Идти наверх

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
31/03/2014

Foto4_def

 

 

Description

Phase III, Multi-center, Randomized, Double-Masked, Sham-Controlled Study of Efficacy and Safety of Lampalizumab intravitreal injections Administered Monthly for 24 Months in Patients with Geographic Atrophy Secondary to AMD.

_MG_8162

If you are interested in taking part in a clinical trial, please call us at 935 950 155 and we will assess whether you are eligible. Further information on trials at research projects.

Интравитреальные инъекцииЭкссудативная или влажная ВМД

Author

Доктор Jordi Monés, M.D., Ph.D.
Номер лицензии COMB: 22.838
Директор
Доктор Медицины и Хирургии
Специалист по Офтальмологии
Специалист по лечению Сетчатки, Макулы и Стекловидного тела

Last modified: 18 September, 2019 - 9:10